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article under the CC BY-NC-ND license (Abstract Background/purpose: Plasma rich in growth factors (PRGFs), which is prepared
from autologous blood from patients, has been reported with regards to bone regeneration
for dental implants. Human dental follicle cells (hDFCs) have the capacity to commit to
multiple cell types such as the osteoblastic lineage. The aim of this study is to evaluate the
effects of PRGFs for mineralization in hDFCs.
Materials and methods: PRGFs was prepared from whole blood centrifuged at 460g for
8 minutes. hDFCs isolated from the dental follicle with collagenase/dispase were cultured with
growth medium or osteogenic induction medium (OIM) containing PRGFs or fetal bovine serum.
Concentrations of the growth factors were examined using an enzyme-linked immunosorbent
assay kit. A cell migration assay was used for two-dimensional movement. Gene expressions
were examined with real-time polymerase chain reaction using a DyNAmo SYBR Green
quantitative polymerase chain reaction kit.
Results: The platelet concentration in PRGF Fraction 2 was 2.14-fold higher than in whole
blood. White blood cells were not detected in PRGFs. Transforming growth factor-b levels were
higher than insulin-like growth factor-1, platelet-derived growth factor-AB and -BB, and
vascular endothelial growth factors in PRGF Fraction 2. Proliferation and migration by hDFCs
increased in OIM supplemented with PRGFs in a dose-dependent manner and were higher in
hDFCs cultured in OIM plus 10% PRGFs compared with OIM plus 10% fetal bovine serum. PRGFsof Maxillofacial Surgery, Nihon University School of Dentistry at Matsudo, 2-870-1 Sakaecho-Nishi,
on-u.ac.jp (T. Kondoh).
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246 H. Okada et alupregulated the gene expression of type I collagen, osteomodulin, alkaline phosphatase, bone
morphogenic protein-4, and transforming growth factor-b in hDFCs.
Conclusion: PRGFs may promote bone regeneration due to it including high levels of growth
factors.
Copyright ª 2016, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Platelet concentration products, which are autologous
constituents of inductive factors obtained from blood,
contain high concentrations of platelets with various
growth factors.1 Platelet-rich plasma (PRP) has been used
in bone augmentation for dental implants.2,3 However, PRP
formulations have different biological activities, depending
on the various protocols used to obtain them.4,5 The system
of plasma rich in growth factors (PRGFs) is a method for
concentrating platelets6,7 and is advantageous as it re-
quires only one centrifugation step and is leukocyte-free,
thus avoiding high levels of proinflammatory cytokines.6
PRGFs allows delivery to the site of injury of a cocktail of
proteins and growth factors that promotes wound healing
and regeneration of tissue and bone.8,9 Numerous studies
have been published describing the benefits of PRGFs
in vivo. However, the majority of studies about the use of
PRGFs only describe the final outcome at the tissue level
and do not investigate the mechanism of PRGFs. Therefore,
investigation of the role of PRGFs in bone and/or tissue
regeneration should involve a study of the biological prop-
erties and molecular functions using a cell culture system.
The dental follicle, an ectomesenchymal tissue that
surrounds the developing tooth germ, contains stem cells
and lineage committed progenitor cells or osteoblast/
cementoblast precursor cells.10 Human dental follicle cells
(hDFCs) also have the capacity to commit to multiple cell
types, not only to cells of the osteoblastic lineage, but also
to cells of adipogenic and neurogenic lineages.11,12 We
previously reported that hDFCs can differentiate into
osteogenic lineage cells in osteogenic induction medium
(OIM) without dexamethasone,13 which has various biolog-
ical effects such as anti-inflammatory properties. In addi-
tion, hDFCs express stem cell markers and growth factor
receptors, and highly express LIM homeobox 8, which is
associated with development of the palatal mesenchyme
and tooth germ.14 In addition, hDFCs are easily accessible
for cell culture and have a higher proliferation capacity.15
According to these findings, we suggested that hDFCs may
be useful for therapy and in basic research of the maxillo-
facial region bone.
In this study, we measured the concentration of growth
factors in PRGFs and examined the effect of the soluble
factors in PRGFs on proliferation and gene expression in
hDFCs treated with PRGF supernatant compared with fetal
bovine serum (FBS). We evaluated the efficacy of PRGFs as
a substitute for engineered bone tissue in the maxillofacial
region.Materials and methods
Preparation of different blood products
For blood product preparation, whole blood from four
young healthy donors (two men and two women, average
age 29.5 years) was collected from the external jugular
vein after informed consent was obtained. Whole blood was
immediately placed into 5-mL sterile extraction tubes
containing 0.5 mL of 3.8% sodium citrate as an anticoagu-
lant. The whole blood was divided into two aliquots.
The first aliquot was used to obtain PRGFs that was
prepared from whole blood, which was centrifuged in
accordance with Anitua’s protocol.6e8 Briefly, tubes were
centrifuged at 460g for 8 minutes. The plasma fraction
(1 mL over the buffy coat) was collected as Fraction 2 (F2),
whereas Fraction 1 (F1) was the layer above F2. PRGF F2
was incubated with 10% calcium chloride solution at 37C
for 1 hour to trigger platelet activation and growth factor
release. Activated PRGF F2 was centrifuged at 3000g for
15 minutes, and then the supernatant was isolated (PRGF
F2 supernatant).
The second aliquot was used to obtain serum. Whole
blood was left for 30 minutes at room temperature and
then centrifuged at 1000g for 15 minutes.
The numbers of blood cells in PRGFs and serum were
immediately measured, and then the samples were stored
at 80C until use.
PRGF extraction was performed according to the
guidelines established by the Ethics Committee of Nihon
University School of Dentistry at Matsudo (Recognition
number: EC14-13-029-1).
Number of blood cells
The numbers of platelets and white blood cells (WBCs) were
counted using XE-2100 (Sysmex, Hyogo, Japan).
Enzyme-linked immunosorbent assay
Concentrations of growth factors including insulin-like
growth factor (IGF)-1, transforming growth factor (TGF)-
b, platelet-derived growth factor (PDGF)-AB and -BB, and
vascular endothelial growth factor (VEGF) were measured
using enzyme-linked immunosorbent assay kits (Quantikine
enzyme-linked immunosorbent assay kits; R&D Systems,
Mckinley, MN, USA) according to the manufacturer’s
instructions.
Table 1 Primers used in Real e time PCR.
Gene Primers bp
Col I a1 F: 50- ggc caa gag gaa ggc caa gt- 30 251
R: 50- tgg tcg gtg ggt gac tct ga- 30
OMD F: 50- cat ctt ctt ctg ctt ccc tca- 30 123
R: 50- gtc aaa gtg ccc ttc tgc tc- 30
ALP F: 50- gtc atc atg ttc ctg gga ga- 30 123
R: 50- gaa ggg gaa ctt gtc cat ct- 30
BMP-2 F: 50- cat gtg gac gct ctt tca at - 30 113
R: 50- gaa gca gca acg cta gaa ga - 30
BMP-4 F: 50- gct agg agc cat tcc gta gt - 30 193
R: 50- cct agc agg act tgg cat aa - 30
TGF-b F:50-gactcgccagagtggttat-30 125
R: 50-agtgtgttatccctgctgtc-30
GAPDH F: 50- atc acc atc ttc cag gag- 30 315
R: 50- atg gac tgt ggt cat gag- 30
Col I a1; type I collagen a chain 1, OMD; osteomodulin, ALP;
Alkaline Phosphatase, BMP; bone morphogenetic protein,
TGF-b; Transforming growth factor b, GAPDH; glyceraldehydes-
3-phosphate dehydrogenase, F Z forward; R Z Reverse.
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hDFCs were obtained using a previously reported method.11
Briefly, normal human impacted third molars were surgi-
cally removed and collected from a patient aged 14 years,
after obtaining informed consent. Dental follicle tissues
were minced with sterilized scalpels and digested in a so-
lution of 0.1-U/mL collagenase type I and 1-U/mL dispase
(Roche, Mannheim, Germany) for 1 hour at 37C. Attached
hDFCs were cultured in 100-mm dishes using mesenchymal
stem cells (MSC) growth medium (GM; Lonza, Walkersville,
MD, USA) in a CO2 incubator (Sanyo, Osaka, Japan) in the
presence of 5% CO2 in air at 37C.
For induction of osteogenic differentiation, hDFCs from
the fifth to sixth passage were seeded at 3.1 103 cells/cm2
in GM. After 24 hours (Day 0), mediumwas replacedwith MSC
OIM (Lonza) consisting of osteogenic basal medium contain-
ing ascorbate, and b-glycerophosphate supplemented with
FBS (OIM-FBS) or PRGFs F2 supernatant (OIM-PRGFs). The
PRGFs that were added to OIM was a mixture of equal vol-
umes of each PRGF sample from the four donors.
Experiments using hDFCs were performed in accordance
with the guidelines established by the Ethics Committee of
Nihon University School of Dentistry at Matsudo (Recogni-
tion number: EC10-036).
Cell numbers
hDFCs were seeded in a 24-well plate at a density of
1  104 cells/well in GM. After 24 hours, medium was
replaced with GM, OIM-FBS, or OIM-PRGFs. Cell numbers
were counted with a Z1 Counter Particle Counter (Beckman
Coulter, Miami, FL, USA).
Cell migration assay
hDFCs were seeded in a 24-well plate at a density of
1  104 cells/well in GM and were cultured in GM for 4 days
until 80% confluent. A scratch was then made on the mono-
layer using a Cell Scratcher (AGC Thecno Glass, Tokyo,
Japan), leaving two separated cell monolayers with a cell-
free gap that was approximately 2-mm wide. Then, the
mediumwas replacedwithGM,OIM-FBS, or OIM-PRGFs. After
72 hours, photographs of hDFCs were taken using a DP12
Microscope Digital Camera (Olympus, Tokyo, Japan). The
areas of migratory cells were measured using Image J (Na-
tional Institutes of Health, Bethesda, MD, USA). Results were
expressed as percent of the migratory cell area per mm2.
Total RNA isolation
Total RNA from hDFCs was isolated using miRNeasy Mini Kits
(Qiagen, Valencia, CA, USA) according to the manufac-
turer’s instructions. RNA was stored at 80C until use.
Real-time polymerase chain reaction
Complementary DNA was synthesized using a GeneAmp RNA
polymerase chain reaction (PCR) kit (Life Technologies,
Carlsbad, CA, USA). Real-time PCR was performed using aDyNAmo SYBR Green qPCR kit (Finnzymes, Espoo, Finland).
The PCR mixture, containing 20-pmol forward and reverse
primers and 2-mL complementary DNA, was subjected to
amplification with a DNA Engine Opticon 1 (BioRad, Her-
cules, CA, USA), and was preheated at 95C for 10 minutes,
followed by 40 cycles of 94C for 15 seconds, 55C for
30 seconds, and 72C for 30 seconds. Gene expression levels
were calculated using the DDCT method with normalization
to glyceraldehyde 3-phosphate dehydrogenase.16 The
primers are shown in Table 1.Statistical analysis
Data are expressed as means  standard deviation of the
three samples. Significance of differences between culture
samples was determined using Student t test and a value of
P < 0.05 was considered to be statistically significant.Results
Concentrations of platelets and WBCs
The platelet concentration in PRGFs F2 was 2.14  0.10-
fold higher than in whole blood, whereas that in PRGF F1
was 0.59  0.19-fold of that in whole blood (Table 2). WBCs
were not detected in PRGFs from any donors. The number
of platelets and WBCs in whole blood and PRGFs varied
among individual donors.Concentrations of growth factors
The concentration of TGF-b was higher in PRGF F2
compared with PRGF F1 and serum, although the levels of
each growth factor varied among individual donors
(Figure 1). The concentrations of IGF-1, PDGF-AB, PDGF-BB,
and VEGF were similar between PRGF F2 and serum, and
Table 2 Numbers of blood cells.
Platelets (104 cells/mL) WBCs (cells/mL)
WB Serum F1 (fold) F2 (fold) WB Serum F1 F2
Donor 1 19.7 0.0 16.2 (0.8) 39.9 (2.0) 3870.0 0.0 0.0 0.0
Donor 2 25.1 0.0 12.3 (0.5) 55.8 (2.2) 3410.0 0.0 0.0 0.0
Donor 3 14.4 0.0 10.6 (0.7) 32.4 (2.3) 3850.0 0.0 0.0 0.0
Donor 4 26.2 0.0 8.7 (0.3) 54.0 (2.1) 5510.0 0.0 0.0 0.0
F1 Z plasma rich in growth factors F1 fraction; F2 Z plasma rich in growth factors F2 fraction; Fold Z number F1 or F2/number WB;
WB Z whole blood; WBCs Z white blood cells.
248 H. Okada et alwere low in PRGF F1 compared with other blood products
(Figure 1).
Next, the PRGF F2 supernatant was isolated by centri-
fugation of PRGF F2 clots in order to investigate the bio-
logical effects of soluble factors in PRGF F2. The
concentration of IGF-1 was slightly increased in the super-
natant compared with that in PRGF F2, whereas the con-
centration of TGF-b was markedly decreased in the
supernatant (Table 3). The concentrations of PDGF-AB,
PDGF-BB, and VEGF were decreased about 50% in the su-
pernatant (Table 3).Cell proliferation
The cell proliferation of hDFCs was increased in OIM sup-
plemented with PRGFs in a dose-dependent manner
(Figure 2). On Culture Day 3, the proliferation was signifi-
cantly higher in hDFCs cultured in OIM-PRGFs (10% and 20%)
compared with cells cultured in OIM-FBS (10%; Figure 2).Figure 1 The levels of growth factors in serum and plasma ric
prepared from four healthy donors. Growth factor concentrations
PRGF fraction 1 and F2 indicates PRGF fraction 2. Bar indicates the
derived growth factor; TGF Z transforming growth factor; VEGF ZThe proliferation ability was similar between OIM-PRGFs
(5%) and OIM-FBS (10%; Figure 2).
Cell migration
A scratch mark was drawn in a cell culture dish to create a
distinct border from which cell migration can be observed.
The cells successfully bridged the gap when supplemented
with the blood products, especially in the case of OIM-
PRGFs (20%) on Culture Day 3 (Figures 3A and 3B). Cell
migration was increased in the culture with OIM-PRGFs
(10%) compared with OIM-FBS (10%), although no statisti-
cal differences were found between OIM-PRGFs and OIM-
FBS (Figure 3B).
Osteogenic gene expression
Figure 4 showed gene expression associated with osteoblast
differentiation in hDFCs cultured in OIM-FBS (10%) or OIM-h in growth factor (PRGF) fractions. Serum and PRGFs were
are expressed as the means  standard deviation. F1 indicates
mean value. IGFZ insulin-like growth factor; PDGFZ platelet-
vascular endothelial growth factor.
Table 3 Levels of growth factors.
Growth factors (pg/mL) F2 F2 supernatant Average F2 supernatant/average F2 (fold)
IGF-I 935.0  128.7 1087.5  209.0 1.2
TGF-b 75,000.0  31,102.0 10,850.0  2820.8 0.1
PDGF-AB 8000.0  1990.0 5050.0  1497.8 0.6
PDGF-BB 1025.0  499.4 397.5  233.9 0.4
VEGF 340.0  186.4 142.5  110.3 0.4
F2 Z plasma rich in growth factors F2 fraction; F2 supernatant Z property of F2 supernatant was described in material and methods;
IGF Z insulin like growth factor; PDGF Z platelet derived growth factor; TGF Z transforming growth factor; VEGF Z vascular endo-
thelial growth factor.
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modulin (OMD), and alkaline phosphatase (ALP) were
significantly higher in hDFCs cultured in OIM-PRGFs
compared with cells cultured in OIM-FBS on Culture Day 3
and Day 7. hDFCs cultured in OIM-PRGFs highly expressed
bone morphogenetic protein (BMP)-4 on Culture Day 3 and
TGF-b on Culture Day 7. BMP-2 expression was higher in
OIM-PRGFs cultures compared with OIM-FBS cultures, but
the difference was not significant.Discussion
PRGFs was used following tooth extraction and around
dental implants to improve healing of the peri-implant bone
and was reported to accelerate bone regeneration in clin-
ical studies.6e8,17,18 It has been reported that PRGFs exert
positive effects on periodontal ligament fibroblasts and
alveolar bone osteoblasts, which could be positive for
periodontal regeneration.6,7 However, recent advances in
stem cell research have revealed the existence of various
types of adult tissue stem cells that contribute to the
functional maintenance of organs and to cell renewal, tis-
sue remodeling, and repair.19,20 hDFCs include mesen-
chymal stem cells that have the capacity to form various
types of cells committed osteoblastic/cementoblastic,10
adipogenic,11 and neurogenic lineages.12 In addition,
hDFCs express the genes associated with development ofFigure 2 Effect of plasma rich in growth factors (PRGFs) on hum
were cultured in growth medium (GM), osteogenic induction medium
supplemented with the indicated PRGF concentrations for 2 or 3 day
** P < 0.01.the palatal mesenchyme and tooth germ,14 and have a
higher proliferation capacity.15 Human dental follicles,
which are a source of hDFCs, can be very easily obtained
during various types of surgical operations, such as the
extraction of impacted teeth. Therefore, hDFC have great
potential for utilization in regenerative cell therapy and in
basic research of the maxillofacial region bone. In this
study, we examined the effect of PRGFs on proliferation
and gene expression in hDFCs, and evaluated the efficacy of
PRGFs as a substitute for engineered bone tissue in the
maxillofacial region.
First, we examined the properties of the PRGFs obtained
from four donors in this study. The platelet concentration in
PRGF F2 appeared to be linked with that in each donor’s
whole blood. A previous report also showed that the
platelet concentration in blood bank PRP was correlated
with the platelet count in the donor whole blood.21 How-
ever, WBCs were not detected in PRGFs (Table 2) from any
donors as in previous reports.6 WBCs, such as macrophages
and lymphocytes, secrete inflammatory cytokines and
reactive oxygen species22 and may induce inflammatory
disorders and ultimately bone loss.23 A previous study sug-
gested that the absence of WBCs in PRGFs drastically re-
duces the amount of these proinflammatory and profibrotic
agents at the site of injury, probably contributing to more
balanced bone tissue healing.6
The concentrations of growth factors associated with
bone generation were measured (Figure 1). Thean dental follicle cell proliferation. Human dental follicle cells
(OIM) supplemented with 10% fetal bovine serum (FBS), or OIM
s. Values represent the means  standard deviation. * P < 0.05.
Figure 3 Effect of plasma rich in growth factors (PRGFs) on migration of human dental follicle cells (hDFCs). hDFCs were cultured
in growth medium (GM), osteogenic induction medium (OIM) supplemented with 10% fetal bovine serum (FBS), or OIM supplemented
with the indicated PRGF concentrations for 3 days. (A) Phase-contrast microscopy shows hDFC migration; (B) quantitation of cell
migration using Image J software (National Institutes of Health, Bethesda, MD, USA). Values represent the means  standard
deviation.
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centration of platelets in PRGF F2 from different donors.
The level of TGF-b in PRGF F2 was higher than that in serum
and PRGF F1, and was higher compared with levels of other
growth factors. TGF-b is a stimulator of both chondrogenic
and osteogenic MSC differentiation, suggesting that this
factor plays a critical role in early- and mid-phase processes
in the endochondral bone healing pathway.24 Other growth
factor levels in PRGF F2 were higher than those in PRGF F1,
although they were similar to those in serum. PDGF is
suggested to be a crucial initiator of bone healing as PDGF
can initiate callus formation through chemotaxis and
mitogenesis of MSCs.25,26 IGF is expressed in the bone ma-
trix and regulates proliferation and maturation of chon-
drocytes to induce hypertrophyy.27 VEGF is an important
factor in angiogenesis that is necessary for the transition
from soft to hard callus.28 The present study revealed that
the PRGFs had a stimulating effect on the initial cell growth
and migration of hDFCs (Figures 2 and 3). Thus, PRGFs may
induce chemotaxis and mitogenesis of progenitor cells in
the osteoblast lineage and accelerate bone healing.
Gene expression of type I collagen a1, OMD, BMP-2,
BMP-4, and TGF-b was examined in hDFCs treated with 10%
PRGF F2 supernatant or 10% FBS. The expression of type I
collagen a1 and OMD was significantly upregulated in hDFCs
with OIM-PRGFs compared with OIM-FBS. Type I collagen isa main matrix protein in bone, and its production is
increased by several factors such as TGF-b. OMD (also
called osteoadherin) is a small leucine-rich proteoglycan
that is specifically located in mineralized tissues, possibly
reflecting a role in collagen fibrillogenesis.29 Upregulation
of matrix protein of type I collagen and OMD by PRGFs may
be useful for bone healing. The expression of ALP, which is
an early marker of osteogenic differentiation, was also
upregulated by PRGFs. Therefore, PRGFs may promote the
deposition of the mineralized bone matrix.
BMPs and TGF-b are stored in the bone matrix and play
important roles in bone modeling and remodeling. BMP-2
and -4 have been suggested to be required for cells to
differentiate into functional osteoblasts.30 TGF-b stimu-
lates the proliferation of osteoblast progenitors.31 The
expression of BMP-2 and -4 were increased in hDFCs with
OIM-PRGFs compared with OIM-FBS, although only BMP-4 on
Culture Day 3 was significantly different. The expression of
TGF-b was significantly elevated in hDFCs cultured with
OIM-PRGFs on Day 7. Previous studies have reported that
osteoblast-like cells or periodontal ligament cells upregu-
late TGF-b production when cultured with xenogenic bone
substitutes or enamel matrix derivatives.32,33 Therefore,
upregulation of TGF-b expression on Day 7 may be related
to the elevation of type I collagen and OMD expression in
hDFCs cultured in OIM-bPRGFs. These findings suggested
Figure 4 Gene expression of type I collagen a1, osteomodulin (OMD), alkaline phosphatase (ALP), bone morphogenetc proteins
(BMPs), and transforming growth factor (TGF )-b in human dental follicle cells. Human dental follicle cells were cultured in growth
medium (GM), osteogenic induction medium (OIM) supplemented with 10% fetal bovine serum (FBS), or OIM supplemented with the
indicated PRGFs concentrations for 3 or 7 days. The gene expression was examined with real-time polymerase chain reaction.
Values represent the means  standard deviation of the results from three independent experiments. * P < 0.05. ** P < 0.01. ***
P < 0.05 compared with Culture Day 0.
Effects of PRGFs on hDFCs 251that PRGFs may be useful for bone regeneration through
upregulation of matrix proteins and growth factors associ-
ated with bone remodeling.
The PRGF F2 supernatant was prepared for addition to
hDFC culture medium according to a previous report6 and
the concentration of growth factors between PRGF F2 and
PRGF F2 supernatant was compared (Table 3). The IGF level
was almost the same between PRGF F2 and PRGF F2 su-
pernatant. The levels of other growth factors were lower in
the supernatant, and the TGF-b level was especially lower.
In a previous report, IGF was not able to bind fibrin(ogen)
directly, but TGF-b showed a high binding affinity to
fibrin(ogen). By contrast, PDGF showed binding to fibrin(-
ogen), but its release from the matrix was relatively
rapid.34 We suggested that our data regarding growth factor
levels in PRGF F2 and its supernatant reflect the informa-
tion from this report.
We examined the effects of PRGF F2 supernatant on
proliferation, migration, and regulation of bone-associated
genes in cultures of hDFCs in this study. However, the levels
and the ratio of growth factors were different between
PRGF F2 and PRGF F2 supernatant. In addition, the bio-
logical effects of PRGF for regeneration involved soluble
factors released from platelets such as growth factors and
scaffolding by fibrin. PRGF clots are three-dimensional
fibrin matrices that can provide transient space for the
key tissue-forming cells. At the same time, the clots act as
a biomolecule delivery system and are transplanted into
lost or damaged bone such as the cavity following toothextraction in clinical and in vivo studies. New in vitro
experimental models are necessary to elucidate all the
biological functions of PRGFs including scaffolds and
release of growth factors.
This study showed that the soluble factors in PRGFs
increased proliferation, migration, and gene expression
that is associated with osteogenic induction using hDFC
cultures. PRGFs are a source of autogenous growth factors
that help with bone regeneration and may be convenient
for clinical application.
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